Literature DB >> 27213532

Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.

Andrew Martin Kilale1,2, Esther Ngadaya1, Julius Muhumuza1,2, Gibson Benard Kagaruki3, Yakobo Leonard Lema1, Bernard James Ngowi3, Sayoki Godfrey Mfinanga1, Sven Gudmund Hinderaker2.   

Abstract

OBJECTIVE: To determine and describe clinical symptoms, demographic characteristics and environmental exposures as determinants of pulmonary mycobacterial diseases among patients examined for tuberculosis in agropastoral communities in Northern Tanzania.
METHODS: This was a cross sectional study. Sputum samples were collected from patients attending three hospitals in Tanzania, and were investigated for pulmonary tuberculosis by microscopy between November 2010 and June 2012. The patients were interviewed about background information, and potential exposure to mycobacteria.
RESULTS: We examined 1,711 presumptive tuberculosis cases where 936 (54.2%) were males and 775 (45.3%) females. Of all the study participants, 277 (16%) were found to have sputum samples positive for mycobacteria; 228 (13%) were smear positive, 123 (7%) were culture positive and 74 (4%) were positive by both smear microscopy and culture. Of the 123 mycobacterial culture positive, 15 (12.2%) had non-tuberculous mycobacteria. Males were more likely than females to be positive for mycobacteria. Factors associated with mycobacterial disease were loss of appetite, age groups below 41 years, and being a male. Among HIV negative patients, loss of appetite, age below 20 years and being a male were associated with being mycobacterial positive. Among HIV positive patients, males and those patients with a persistently coughing family member were more likely to harbor mycobacteria.
CONCLUSION: The findings in this study show that both M. tuberculosis and non-tuberculous mycobacterial strains were prevalent in the study community. Some risk factors were identified. Although the reported predictors may improve screening for mycobacterial diseases, their use requires some precaution.

Entities:  

Mesh:

Year:  2016        PMID: 27213532      PMCID: PMC4877068          DOI: 10.1371/journal.pone.0153711

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Mycobacteria are important acid-fast pathogens ranging from obligate intracellular parasites to environmental species []. Some mycobacteria are saprophytes and others are obligate parasites, most of them are found in soil and water in a free-living form or in diseased tissue of animals. Diseases caused by mycobacteria and the role of the environment as a reservoir of infections to human is well documented [,]. In communities where livestock, wildlife and humans share the same environment, there is opportunity for close interaction and increased potential risk of mycobacterial infection []. Mycobacterial diseases cause considerable morbidity and mortality in patients with human immunodeficiency virus (HIV) infection [,]. There is evidence that HIV is a major risk factor for clinical tuberculosis as well as for illnesses associated with certain opportunistic non-tuberculosis mycobacteria, such as Mycobacterium avium-intracellulare [. In addition to altering the risk of diseases caused by mycobacteria, the clinical characteristics of tuberculosis in HIV-infected individuals produce a more disseminated infection [ and are more likely to be sputum-negative than persons without HIV []. Despite reports of existence of other mycobacterial infections in areas known to have high human-environment-livestock/wildlife interaction, available diagnosis is mainly for pulmonary tuberculosis. This is due to difficulties in diagnosing mycobacterial diseases as the clinical manifestation of most of mycobacterial lung diseases are often similar to those of many other diseases. Lack of a reliable, rapid, and inexpensive diagnostic tests to distinguish the pulmonary mycobacterial diseases remains a major obstacle to effective control of tuberculosis in sub-Saharan Africa where tuberculosis and HIV co-infection is common [10]. Sputum smear microscopy, the standard diagnostic test for pulmonary tuberculosis in low-income countries, fails to diagnose a large proportion of the patients [10,11]. Some earlier studies reported on how well clinical signs and symptoms can predict pulmonary mycobacterial diseases [12-14]. In HIV-infected adults with unexplained cough and negative sputum smears, the World Health Organization guidelines recommend clinical judgment and chest radiography for diagnosing tuberculosis. To our knowledge, there is sufficient documentation of studies that have attempted to assess the diagnostic performance of clinical signs and symptoms [10,15]. Specifically, we aimed to describe the following among patients examined for pulmonary tuberculosis in pastoral communities in Northern Tanzania: 1) the demographic characteristics, 2) the associations between determinants and mycobacterial disease, and 3) the association between determinants and mycobacterial disease by HIV status.

Methods

Study design

This was a cross-sectional hospital-based study to assess risk factors for mycobacterial disease among hospital patients.

Study area and population

We enrolled presumptive tuberculosis patients who attended the Haydom Lutheran Hospital in Mbulu district of Manyara region, the Enduleni Catholic Hospital in Ngorongoro district of Arusha region and the Mount Meru regional Hospital located in Arusha Municipal in northern Tanzania. We selected a study area known for its pastoral communities, and we selected three hospitals where we had previous experience in studying mycobacterial diseases and with a substantial number of patients examined for tuberculosis. We selected both government and private-not-for-profit. The study participants presented at the tuberculosis clinic for investigation. The participants had a reason or symptom that caused the clinician to refer them for investigation for tuberculosis, such as persistent cough for two weeks or more, loss of appetite, weight loss, evening fever, and hemoptysis. For the purpose of this study, pastoralism refers to communities with farmers who grow crops and or keep livestock searching pastures and water. A presumptive tuberculosis patient (formerly “suspect”) refers to an individual presenting to the health facility and being investigated for tuberculosis. In our study a tuberculosis case is an individual bacteriologically confirmed by smear microscopy or culture of a sputum sample. Literacy is the ability to read and write and speak Swahili (the national language). Education level is the highest grade of education that an individual has completed. Semi-urban means settings with business and employment as well as farming activities.

Data collection

We collected two sputum samples (spot and morning) from all consenting study participants. A specimen taken on the spot was used for routine examination at the hospital for immediate follow-up treatment, and the rest of the samples along with the morning sputum sample were transported to the Central Tuberculosis Reference Laboratory (CTRL) in Dar es Salaam. Sputum samples collected at Enduleni Catholic and Haydom Lutheran Hospitals were packed and transported to Mt. Meru Regional Hospital in Arusha on the same day of collection. Together with the samples collected at Mt. Meru Regional Hospital, the samples from Enduleni Catholic and Haydom Lutheran Hospitals were transported to the CTRL in Dar es Salaam on the second day from the day of collection. Cool boxes packed with ice cubes were used to maintain the temperature of the samples during transportation. Transport of the samples was done using public buses. In Dar es Salaam, the samples were send to the CTRL on the same day of arrival. Collection of sputum samples and processing for culture was done according to the national tuberculosis guidelines [16]. All study participants were interviewed about their demographic background and symptoms related to their illness, and about risk factors for mycobacteria especially tuberculosis. Interviews were conducted using a structured questionnaire. The interview was in Swahili, and the research assistants filled the questionnaire in English. Data collection was conducted from November 2010 to June 2013. Presence of mycobacteria was bacteriologically confirmed either by microscopy or culture.

Laboratory procedures

The sputum smears were stained using the Ziehl-Neelsen technique. Only the early morning specimen was used for culture because it was the most likely to grow mycobacteria, and it was least likely to be contaminated with other bacteria [17]. After decontamination and digestion of sputum samples with 4% sodium hydroxide (NaOH), a sterile phosphate buffer pH 6.8 was added to neutralize the effect of NaOH. The samples were concentrated by centrifugation at 3000g for 15 minutes. Supernatant was discarded and sediment was re-suspended in small amount (1–2 ml) of phosphate buffer and inoculated on the slants of solid Lowenstein Jensen (LJ) medium. Culture was considered positive if it grew any visible colonies. Samples that failed to show any growth after eight weeks of LJ incubation were classified as negative. Oxygen Preference Test and Twin 80 Test was further carried out. Species identification was done using polymerase chain reaction (PCR). Growth on LJ media containing para-nitrobenzoic acid (PNB 500μg/ml) was considered as non-tuberculous mycobacteria. Participant HIV status was obtained from clinical records of the three hospitals.

Ethical considerations

This study was approved by theNational Health Research Ethics Review Committee (NatREC) of the Medical Research Coordination Committee (MRCC) at the National Institute for Medical Research (NIMR) in Tanzania prior to its implementation (Approval Reference number: NIMR/HQ/R.8a/Vol. IX/1009). Furthermore, permission was sought and granted by regional, district and health facility authorities as required. Patients obtained information about the purpose, risks, benefits and comfort of the study participants either by reading or having the consent form read to them by the research assistants. All consenting patients signed the consent form prior to interviews and collection of sputum samples. The participants were free to decline interview at any point in time. Research assistants were trained on all important issues before commencement of data collection.

Data management

Data were double entered, validated and cleaned using EpiData version 3.1 (Epidata Association, Odense, Denmark) and STATA version 11 (STATA Corp Inc., TX, USA) for cleaning and analysis. The Pearson Chi square test was used to compare proportions between the groups. We considered p<0.05 as statistically significant. Multiple logistic regressions were used for assessing determinants of mycobacterial disease. Crude and adjusted odds ratios (OR) with 95% confidence intervals (CI) were reported. Variables giving p≤0.2 in the univariate analysis were included as adjustment factors in the final multivariable regression model, and included sex, age, education, residence, agro-pastoralist, coughing family member, and smoking. Missing values were excluded from the regression models; the highest number of missing values was for the variable ‘age group’, where 6 values out of 159 (4%) were missing among HIV positives and 30 values missing among 505 (6%) HIV negatives.

Results

Demographic characteristics

A total of 1711 individuals were examined for tuberculosis and the socio-demographic characteristics of the study population are summarized and presented in Of all the participants, 729 (42.6%) were from semi-urban and 979 (57.2%) were from rural areas. The mean age in years and the standard deviation (SD) of the study participants was 46 (20) for males and 44(20) for females. HIV test results were present in 664 participants of whom 159 (24%) were HIV positive (). Of the sputum samples from 1711 study participants who were identified through symptoms and signs of pulmonary tuberculosis, 277 (16%) were confirmed to have mycobacteria by smear microscopy and culture. Of the 1711 samples 228 (13%) were positive by smear microscopy, 123 (7%) by culture and 74 (4%) by both smear microscopy and culture. Among the 123 culture positive, 15 (12.2%) had non-tuberculous mycobacteria. Males were more likely than females to be positive for mycobacteria.

Association between determinants and mycobacterial disease

In , we show the association between the assessed potential determinants and mycobacterial disease among the study participants. We found higher risk of mycobacterial disease among men, and higher risk among those 40 years or younger compared to those over 50. Loss of appetite was the only symptom significantly associated with being mycobacterial positive among study participants. Of all the study participants, 935 (55%) presented with a persistent cough lasting for two or more weeks (), 508 (30%) with loss of weight, 468 (27%) evening fever and 17 (6%) hemoptysis. In , we show a comparison of the proportion of reported symptoms by their HIV status. a) Proportion of patients with symptoms for investigation of mycobacterial diseases among 1711 patients attending three tuberculosis clinics in Northern Tanzania, 2010 12. b) Reported symptoms by 664 patients investigated for mycobacterial diseases by HIV status in Northern Tanzania, 2010–12. *Adjustment factors included: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking.

Association between determinants of and mycobacterial disease among study participants with known HIV status

In , we present an assessment of the association between mycobacterial diseases and its determinants among the HIV positive participants: men were more likely than women to be positive for mycobacteria, and the presence of a family member with a persistent cough also predicted being positive for mycobacteria. In we also show that among the HIV negative participants we found a higher risk of tuberculosis among men than women, among young (≤20 years) patients compared with adults over 50 years, and among those who presented with loss of appetite as a symptom for their illness. *Adjustment factors included: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking. **Some cells had expected values < 5 making the analysis invalid. * Adjustment factors included in the final model were: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking.

Discussion

The current study shows that pulmonary mycobacterial diseases were common among the investigated patients. Men had higher risk of mycobacterial diseases both among HIV positives and HIV negatives, as well as the HIV positive patients who had a family member with persistent cough. Young adults and patients presenting with loss of appetite also were at increased risk of mycobacterial disease. We demonstrate that non-tuberculous mycobacteria were prevalent among the participants examined in the agropastoral communities in northern Tanzania. Since patients with non-tuberculous mycobacteria present with acute or chronic illness that is clinically and radiologically indistinguishable from M. tuberculosis, misdiagnosis of non-tuberculous mycobacteria infection could therefore lead to inappropriate anti-tuberculosis treatment. In Tanzania, the major diagnostic method for tuberculosis is sputum smear microscopy with culture only done at the CTRL and some few zonal laboratories. For that case non-tuberculous mycobacteria cases with positive smears will continue to be misclassified as M. tuberculosis and subsequently treated with conventional anti-tuberculosis drugs to which some of them may be resistant and a large majority of non-tuberculous mycobacterial infections will remain undetected.

Occurrence of mycobacterial diseases in the study area

Information on the prevalence of diseases such as tuberculosis is vital for planning, implementation and evaluation of control strategies at local, national and global levels. In the current study, we report that the majority of the patients found to have mycobacteria had a positive sputum smear. We think part of the reason that many acid fast bacilli positives were negative on culture may have been due to long transport time. Still the proportion of “presumptive tuberculosis patients” who were finally reported to be mycobacterial positive (the yield) was higher than the national and regional smear positive tuberculosis rates [18]. Reports from other African countries have also documented varying prevalence of mycobacteria, indicating their public health importance in agropastoral communities [19,20]. Factors such as HIV, patient’s understanding about the disease, and an increased role of environmental sources and livestock/wildlife reservoirs have been reported to play role in the existence of mycobacterial diseases in humans [2,21,22].

Association between demographic determinants and mycobacterial diseases

Diagnosis of pulmonary tuberculosis based on a combination of clinical symptoms, sputum microscopy for acid-fast bacilli and chest radiography have been reported to be fairly sensitive, but nonspecific [23]. A study conducted earlier reported that age and symptoms were useful in predicting and screening for smear-negative pulmonary tuberculosis suspects and cases [24]. Predictors of mycobacterial diseases reported in this study were in line with those reported in a study conducted to evaluate the clinical, diagnostic and epidemiological characteristics of patients suspected to have pulmonary tuberculosis in Ethiopia [23]. This observation indicates that if used as a tool to support the diagnosis of mycobacterial diseases, clinical symptoms are useful, although their use may require some caution. The general rule in diagnosing mycobacterial diseases, including pulmonary tuberculosis involves examination of a patient with a cough or expectoration for two or more weeks by smear microscopy or chest radiograph [25]. In addition, in order to find patients with mycobacterial diseases, clinicians inquire about symptoms, risky exposures and habits that may suggest the need for further investigation [24]. In the current study, we found that sex, age and loss of appetite were associated with being mycobacteria positive, regardless of the HIV sero-status of the individual. Our findings align well with studies conducted in other developing countries [26-29].

Association between potential determinants and mycobacterial diseases by HIV status

Among the mycobacterial diseases associated with HIV infection, tuberculosis is of particular importance [30]. People infected with HIV have ten times higher risk of developing tuberculosis than healthy people, and pulmonary tuberculosis is still the most common form [31]. Co-infection with HIV has a major effect on the natural history of many infectious diseases, particularly mycobacterial diseases [32]. HIV infection has been reported to affect the diagnosis of pulmonary tuberculosis in HIV positive patients [33]. In our study, we found that among HIV positive individuals, having a family member with a persistent cough was associated with being mycobacteria positive. It is well known that persons in the household of a tuberculosis patient are exposed to the bacteria and may develop disease, but for clinical practice, this is not among the “classic” risk factors for identifying patients to be examined for tuberculosis. In our study, this was not a significant risk factor among HIV negative patients, but for HIV positive patients, it was a very strong risk factor. Although there is no conclusive evidence that HIV sero-positive persons are more likely to acquire tuberculosis infection than HIV sero-negative individuals given the same degree of exposure [34], the risk of rapid progression is much greater among persons with HIV infection, as HIV impairs the host's ability to contain new tuberculosis infection. HIV co-infection also increases the risk of progression of recently acquired infection to active disease [34,35]. The impact of HIV on the epidemiology, natural history, and clinical presentation of mycobacterial diseases, especially tuberculosis, has been well documented in previous studies, and it may explain the reported findings [36,37]. The reported and observed limited clinical symptoms show that when diagnosing mycobacterial diseases in persons with known or possible HIV infection, one has to consider using an appropriate diagnostic and screening approach. Although screening for mycobacterial diseases using symptoms does not require expensive equipment or specialized health personnel, the sensitivity and specificity of symptoms as a tool for diagnosis of tuberculosis has been reported to be lower in immune suppressed HIV individuals [33]. This study shows that for HIV negative individuals who had a family member who had been coughing for two or more weeks, being a male and aged 20 years or younger were significantly associated with being mycobacteria positive. Other studies show that screening by cough alone in HIV positive patients has low sensitivity [38-42], with up to 86% of tuberculosis cases being missed. In a study conducted in Cambodia, it was reported that the sensitivity of using symptoms rose when fever and weight loss were included as symptoms of mycobacterial disease [40]. This study has some limitations. Assessment of the HIV status of the suspected tuberculosis patients involved in this study relied on patient records available at the health facilities. As part of the national policy, all suspected tuberculosis patients are tested for HIV. However, due to poor record keeping and logistical issues, we found that more than half of the tuberculosis patients lacked HIV test results in the health facility register. This resulted to a lower strength of our associations, and care must be taken in interpretation when no associations between determinant and mycobacterial disease are found. Also, in the selection of all participants by symptoms, even the comparison group represents “suspects”, not healthy individuals. That means we already selected those with symptoms, so we cannot really say how well symptoms predict mycobacterial disease such as tuberculosis in the population, only how well it predicts disease among suspects. This will confound and weaken the associations between symptoms and disease, and in our study many symptoms will not predict disease in the normal population. Furthermore, many variables (e.g. symptoms) depend on participantsrecall and understanding about the disease and thus do not always represent the objective reality. However, this parallels the situation for clinicians, who are often more dependent on recall than objective reality.

Conclusion

The findings in this study show that both M. tuberculosis and non-tuberculous mycobacterial strains were prevalent in the study community. The high proportion of nontuberculous mycobacteria among the participants indicates clinical and environmental occurrence and possible human-environment-livestock risks of cross transmission. Some risk factors were identified which may improve screening for mycobacterial diseases, but their use requires some precaution.
Table 1

Demographic characteristics of 1711 patients examined for tuberculosis in three hospitals of Northern Tanzania, 2010–12.

Demographic characteristicTuberculosis suspects examined
n%
Total1711100.0
Sex
Male92754.2
Female77545.3
Missing90.5
Age group
≤201488.6
21–3027616.1
31–4036521.3
41–5026115.3
>5058734.3
Missing744.3
Education level
No formal education61435.9
Primary school72842.6
Secondary school29017.0
Higher education492.9
Missing301.8
Residence
Rural97957.2
Semi-urban72942.6
Missing30.2
Literacy
Literate106762.4
Illiterate62236.4
Missing221.3
Agropastoral involvement
Primarily pastoralists62536.5
Primarily peasants105361.5
Missing331.9
HIV status
Positive1599.3
Negative50529.5
Test not done104761.2
Table 2

Determinants of mycobacterial diseases among 1711 patients examined for tuberculosis in three hospitals of Northern Tanzania, 2010–12.

DeterminantTotal SuspectsMycobacteria (+)OR (95%CI)AOR* (95%CI)
nn (%)
Total1711277 (16.2)  
Demographic characteristics
Sex
Male927171 (18.4)1.5 (1.1–1.9)1.5 (1.1–2.0)
Female776104 (13.4)REF
Missing82 (25.0)
Age group
≤2014829 (19.6)1.7 (1.0–2.7)1.6 (1.0–2.9)
21–3027655 (19.9)1.7 (1.2–2.5)1.9 (1.2–2.9)
31–4036573 (20.0)1.7 (1.2–2.4)1.7 (1.2–2.6)
41–5026136 (13.8)1.1 (0.7–1.7)1.0 (0.6–1.6)
>5058775 (12.8)REFREF
Missing749 (12.2)
Level of education
No formal education728123 (16.9)1.3 (1.0–1.7)0.9 (0.6–1.4)
Primary School29061 (21.0)1.7 (1.2–2.4)1.1 (0.7–1.9)
Secondary School496 (12.2)0.9 (0.4–2.1) 0.5 (0.2–1.4)
Higher Education61584 (13.7)REF
Missing293 (10.3)
Residence
Semi-urban978159 (16.3)REF
Rural730118 (16.2)1.0 (0.8–1.3)
Missing30 (0.0)
Education status
Literate1067190 (17.8)REF
Illiterate62384 (13.5)0.7 (0.5–1.0)
Missing213 (14.3)
Agropastoral involvement
Primarily peasants1053186 (17.7)REF
Primarily pastoralists62687 (13.9)0.8 (0.6–1.0)
Missing324 (12.5)
Environmental factors
Family size
6 or less562101(18.0)0.8 (0.6–1.1)0.9 (0.6–1.2)
More than 61149177 (15.4)REF
Contact with person with tuberculosis
Yes23537 (15.7)1.0 (0.7–1.4)
No1413230 (16.3)REF
 Missing6410 (15.6)  
Shared a room with domestic animals    
Yes56476 (13.5)0.8 (0.6–1.0)1.1 (0.5–2.2)
No1136198 (17.4)REF
Missing113 (27.3)
Shared water source with animals
Yes58980 (13.6)0.7 (0.6–1.0)0.7 (0.3–1.5)
No1114195 (17.5)REF
Missing82 (25.0)
Presence of family member with cough
Yes35353 (15.0)0.9 (0.7–1.3)
No1328218 (16.4)REF
Missing306 (20.0)
Smoking
Yes43366 (15.2)0.9 (0.7–1.3)
No1257205 (16.3)REF
Missing216 (28.6)
Keeping animals
Yes62586 (13.8)0.8 (0.6–1.0)0.8 (0.4–1.7)
No1053186 (17.7)REF
Missing335 (15.2)
Previously treated for tuberculosis
Yes9210 (10.9)0.7 (0.4–1.3)
No1605263 (16.4)REF
Missing154 (26.7)
Symptoms
Cough
Yes935147(15.8)0.9 (0.7–1.2)
No771128(16.6)REF
Missing52 (40.0)
Hemoptysis
Yes10717 (16.0)1.0 (0.6–1.7)0.9 (0.5–1.9)
No1598257 (16.1)REF
Missing63 (33.3)
Evening fever
Yes46875 (16.1)1.0 (0.8–1.3)1.0 (0.7–1.6)
No1230199 (16.2)REF
Missing133 (18.8)
Loss of weight
Yes50880 (15.8)1.0 (0.7–1.3)
No1191193 (16.2)REF
Missing124 (26.7)
Loss of appetite
Yes28562 (21.8)1.6 (1.2–2.2)2.1 (1.4–3.2)
No1414211 (15.0)REF
 Missing124 (26.7)  

*Adjustment factors included: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking.

Table 3

Determinants of mycobacterial disease among 159 HIV positive patients examined for tuberculosis in northern Tanzania, 2010–12.

DeterminantTotal SuspectsMycobacteria (+)OR (95%CI)AOR* (95%CI)
 nn (%)
Total15921 (13.2)
Demographic characteristics
Sex
Male7815 (19.2)3.0 (1.1–8.1)2.8 (1.0–8.0)
Female816 (7.4)REFREF
Age group
≤2019-**
21–30273(11.1)1.1 (0.2–7.5)
31–405412(22.2)2.6 (0.5–12.7)
41–50334(12.1)1.2 (0.2–7.5)
>50202(10.0)REF
Missing6-
Level of education
No formal education10413(12.5)**
Primary School265(19.2)**
Secondary School30 (0.0)**
Higher Education253(12.0)REF
Residence
Semi-urban11914(11.8)REF
Rural407(17.5)1.6 (0.6–4.3)
Education status
Literate13318(13.5)REF
Illiterate263(11.5)0.8 (0.2–3.1)
Agropastoral involvement
Primarily peasants13517(12.6)REF
Primarily pastoralists224(18.2)1.5 (0.5–5.1)
Missing2-
Environmental factors
Family size
6 or less638(12.7)REF
More than 69657(15.4)0.9 (0.3–3.0)
Contact with person with tuberculosis
Yes20 (0.0)**
No15119(12.6)REF
 Missing62(33.3) 
Shared a room with domestic animals
Yes233(13.0)1.0 (0.3–3.7)
No13618(13.2)REF
Shared water source with animals
Yes193(15.8)1.0 (0.3–3.9)
No11918(15.1)REF
Presence of family member with cough
Yes32(66.7)15.0 (1.3–173.9)11.05 (1.1–175.3)
No15318(11.8)REF
Missing31(33.3)
Smoking
Yes143(21.4)2.0 (0.5–8.0)
No14317(11.9)REF
Missing21(50.0)
Keeping animals
Yes224(18.2)1.5 (0.5–5.1)
No13517(12.6)REF
Missing20 (0.0)
Previously treated for tuberculosis
Yes9-**
No14921 (14.1)REF
Missing11 (100)
Symptoms
Cough
Yes6510 (15.4)1.4 (0.6–3.5)
No9411 (11.7)
Missing--
Hemoptysis
Yes133 (23.1)2.1 (0.5–8.5)
No14618 (12.3)
Missing--
Evening fever
Yes316 (19.4)1.8 (0.6–5.1)
No12815 (11.7)
Missing--
Loss of weight
Yes346 (17.6)1.6 (0.6–4.4)
No12515 (12.0) REF
Missing--
Loss of appetite
Yes276 (22.2)2.2 (0.8–6.4)1.33 (0.3–5.2)
 No13215 (11.4) REF 

*Adjustment factors included: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking.

**Some cells had expected values < 5 making the analysis invalid.

Table 4

Determinants of mycobacterial disease among 505 HIV negative patients examined for tuberculosis in Northern Tanzania, 2010–12.

DeterminantTotal SuspectsMycobacteria (+)OR (95%CI)AOR* (95%CI)
nn (%)
Total50582 (16.2)
Demographic characteristics
Sex
Male26449 (18.6)1.4 (0.9–2.3)2.2 (1.3–3.8)
Female23933 (13.8)REF
Missing2-
Age group
≤204111 (26.8)2.5 (1.1–5.5)2.5 (1.0–6.3)
21–307812 (15.4)1.2 (0.6–2.6)1.2 (0.6–2.8)
31–407918 (22.8)2.0 (1.0–3.9)1.8 (0.8–3.7)
41–505910 (16.9)1.4 (0.6–3.0)1.8 (0.6–3.2)
>5021828 (12.8)REF
Missing303 (10.0)
Level of education
No formal education15532 (20.6)1.6 (1.0–2.7)
Primary5810 (17.2)1.3 (0.6–2.7)
Secondary71 (14.3)1.0 (0.1–8.7)
Higher27739 (14.1)REF
Missing8-
Residence
Semi-urban17332(18.5)REF
Rural33250(15.1)0.8 (0.5–1.3)
Education status
Literate22043(19.5)REF
Illiterate27939(14.0)0.7 (0.4–1.1)
Missing6-
Agropastoral involvement
Primarily peasants16636(21.7)REF
Primarily pastoralists33846(13.6)0.6 (0.4–0.9)
Missing1-
Environmental factors
Family size
6 or less13525(18.5)REF
More than 637057(15.4)0.8 (0.4–1.5)
Contact with person with tuberculosis
Yes13022(16.9)1.1 (0.6–1.8)2.1 (1.0–4.5)
No36559(16.2)REF
 Missing101(10.0)  
Shared a room with domestic animals
Yes31343 (13.7)0.6 (0.4–0.1)1.4 (0.4–5.0)
No19139 (20.4)REF
Missing1-
Shared water source with animals
Yes30641 (13.4)0.6 (0.4–1.0)0.6 (0.2–2.0)
No19941 (20.6)REF
Presence of family member with cough
Yes20428 (13.7)0.7 (0.4–1.2)0.7 (0.3–1.7)
No29654 (18.2)REF
Missing5-
Smoking
Yes22430 (13.4)0.7 (0.4–112)0.9 (0.5–1.8)
No27751 (18.4)REF
Missing41 (25.0)
Keeping animals
Yes33846 (13.6)0.6 (0.4–0.9)0.5 (0.2–1.6)
No16636 (21.7)REF
Missing1-
Previously treated for tuberculosis
Yes283 (10.7)0.6 (0.2–2.0)
No47479 (16.7)REF
Missing2-
Symptoms
Cough
Yes39559 (14.9)0.7 (0.4–1.1)
No11023 (20.9)REF
Missing--
Hemoptysis
Yes456 (13.3)0.8 (0.3–1.9)
No45976 (16.6)REF
Missing1-
Evening fever
Yes20127 (13.4)0.7 (0.4–1.2)0.7 (0.4–1.3)
No30455 (18.1)REF
Missing--
Loss of weight
Yes24538 (15.5)0.9 (0.6–1.4)
No25844 (17.1)REF
Missing2-
Loss of appetite
Yes13129 (22.1)1.7 (1.0–2.8)2.8 (1.5–5.2)
No37353 (14.2)REF
 Missing1-  

* Adjustment factors included in the final model were: Sex, Age, Education, Residence, Agropastoralist, Coughing family member, and Smoking.

  36 in total

1.  Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa.

Authors:  C Lienhardt; K Fielding; J S Sillah; B Bah; P Gustafson; D Warndorff; M Palayew; I Lisse; S Donkor; S Diallo; K Manneh; R Adegbola; P Aaby; O Bah-Sow; S Bennett; K McAdam
Journal:  Int J Epidemiol       Date:  2005-05-24       Impact factor: 7.196

2.  Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Authors:  J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

3.  Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia.

Authors:  A Tamhane; P Chheng; T Dobbs; S Mak; B Sar; M E Kimerling
Journal:  Int J Tuberc Lung Dis       Date:  2009-03       Impact factor: 2.373

Review 4.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 5.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 6.  Improving diagnosis of pulmonary tuberculosis among HIV/AIDS patients: literature review and experience in a teaching hospital in Indonesia.

Authors:  Lidya Rewata; Merrin Rutherford; Lika Apriani; Willem Janssen; Andri Rahmadi; Ida Parwati; Arto Yuwono; Reinout van Crevel
Journal:  Acta Med Indones       Date:  2009-07

7.  Mycobacteria causing human cervical lymphadenitis in pastoral communities in the Karamoja region of Uganda.

Authors:  J Oloya; J Opuda-Asibo; R Kazwala; A B Demelash; E Skjerve; A Lund; T B Johansen; B Djonne
Journal:  Epidemiol Infect       Date:  2007-06-29       Impact factor: 2.451

8.  A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda.

Authors:  W Were; D Moore; P Ekwaru; G Mwima; R Bunnell; F Kaharuza; G Rutherford; J Mermin
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

9.  Clinical determinants of tuberculosis screening.

Authors:  D L Palmer; G H Soo Hoo; R L Sopher
Journal:  South Med J       Date:  1981-02       Impact factor: 0.954

10.  An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.

Authors:  Willy Ssengooba; David P Kateete; Anne Wajja; Eric Bugumirwa; Gerald Mboowa; Carolyn Namaganda; Germine Nakayita; Maria Nassolo; Francis Mumbowa; Benon B Asiimwe; James Waako; Suzanne Verver; Philippa Musoke; Harriet Mayanja-Kizza; Moses L Joloba
Journal:  Tuberc Res Treat       Date:  2012-12-04
View more
  2 in total

1.  Assessment of sputum smear-positive but culture-negative results among newly diagnosed pulmonary tuberculosis patients in Tanzania.

Authors:  Nicholaus Peter Mnyambwa; Esther S Ngadaya; Godfather Kimaro; Dong-Jin Kim; Rudovick Kazwala; Pammla Petrucka; Sayoki G Mfinanga
Journal:  Int J Gen Med       Date:  2017-07-12

2.  Tween 80 Improves the Acid-Fast Bacilli Quantification in the Magnetic Nanoparticle-Based Colorimetric Biosensing Assay (NCBA).

Authors:  Cristina Gordillo-Marroquín; Héctor J Sánchez-Pérez; Anaximandro Gómez-Velasco; Miguel Martín; Karina Guillén-Navarro; Janeth Vázquez-Marcelín; Adriana Gómez-Bustamante; Letisia Jonapá-Gómez; Evangelyn C Alocilja
Journal:  Biosensors (Basel)       Date:  2022-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.